BIA welcomes Canary Wharf Group and Kadans Science Partner as annual supporters
London, UK – 19 May 2025 - The BioIndustry Association (BIA) today announces that Canary Wharf Group (CWG) and Kadans Science Partner (Kadans) have joined as annual supporters. This is a move that speaks to the strength of BIA and the vitality of the UK life sciences ecosystem.
CWG is the developer of the largest urban regeneration project in Europe - a thriving mixed-use community. The Wharf is home to a growing life sciences and healthcare community of over 40 companies and, in partnership with Kadans, is developing One North Quay – a flagship life sciences development in London. The facility will provide purpose-built laboratories, workspace, manufacturing provision and community facilities for companies tackling some of the world’s most pressing health challenges.
Kadans, a European-wide organisation, has built a network across the continent of researchers, entrepreneurs and innovators, with the hope of bringing people together to overcome global challenges. Kadans is dedicated to providing the best spaces for life sciences innovation to thrive.
CWG and Kadans’ support of the BIA is an acknowledgement of the UK’s central place - and UK biotech’s unique position – in the heart of international scientific innovation.
Steve Bates OBE, Chief Executive of the BIA, said:
I’m delighted that Kadans Science Partner and Canary Wharf Group are becoming annual supporters of the BIA - it’s a strong endorsement of our supportive ecosystem.
The UK life science landscape is changing fast, with start-ups and scale-ups in techbio, cell and gene and antibody technology. The UK saw the largest biotech raise of 2025 so far and we look forward to being the home of the next generation of world-changing life science companies.
Mairi Dillon, Associate Director – Science Ecosystem at CWG, added:
Our relationship with the BIA over the past two years has been one of close collaboration, and we are delighted to be further strengthening this partnership. We have a thriving Life Sciences and Healthcare community at Canary Wharf, including leading organisations like Genomics England, the MHRA, hVIVO and AviadoBio.
Across our wider neighbourhood and through our partnership with Kadans Science Partner at One North Quay, we continue to make significant investments to expand the ecosystem further in our ambition to become an internationally recognised life sciences hub. In this journey, partnership, advocacy, and connectivity are essential, and we look forward to supporting key BIA initiatives such as improving access to capital, catalysing the potential of techbio and streamlining regulatory pathways.
Qaisar Rafiq, European Business Development Director at Kadans Science Partner, said:
We are proud to strengthen our relationship with BIA and support the UK’s thriving life sciences sector. The BIA is at the forefront of championing innovation, shaping policy and fostering collaboration across the biotech and life sciences sector. As strong believers in the power of innovation and collaboration, we are proud to stand alongside the BIA in advancing the UK’s position as a global leader in bioscience.
We look forward to contributing to the vibrant community it represents and helping to accelerate the next generation of scientific breakthroughs across the UK.
